Financial Gravity Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30 Hold
4
﹤0.01% 899
2025
Q4
$47 Hold
4
﹤0.01% 700
2025
Q3
$31 Buy
+4
New +$28 ﹤0.01% 915
2025
Q1
$38 Buy
+4
New +$50 ﹤0.01% 1000
2024
Q2
$55 Sell
4
-2
-33% -$28 ﹤0.01% 1212
2024
Q1
$97 Sell
6
-7
-54% -$108 ﹤0.01% 965
2023
Q4
$205 Buy
+13
New +$213 ﹤0.01% 1039
2021
Q3
$48K Buy
+7
New +$324 0.02% 584
2019
Q4
Sell
-759
Closed -$15K 1602
2019
Q3
$15K Buy
759
+745
+5,321% +$17.5K 0.01% 521
2019
Q2
$0 Sell
14
-3
-18% -$66 ﹤0.01% 1523
2019
Q1
$0 Buy
+17
New +$295 ﹤0.01% 1469

Other funds holding NEO

Financial Gravity Asset Management's NEO Position: Q1 2026 in Review

Financial Gravity Asset Management held its NeoGenomics (NEO) position steady in Q1 2026 at 4 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Financial Gravity Asset Management first reported a position in NEO in Q1 2019 and has held it in 11 quarters since. The position peaked at $48K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Financial Gravity Asset Management held 4 shares of NeoGenomics worth $30 as of Q1 2026.
  • Financial Gravity Asset Management left its NeoGenomics share count unchanged in Q1 2026.
  • NeoGenomics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #899 holding.
  • Financial Gravity Asset Management first reported a position in NeoGenomics in Q1 2019 and has held it in 11 quarters since.
  • Financial Gravity Asset Management's NeoGenomics position peaked at $48K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.